asco gu 2013: tivo 1 study shows tivozanib an option for renal cell carcinoma: dr robert motzer
Published 11 years ago • 397 plays • Length 6:19Download video MP4
Download video MP3
Similar videos
-
2:42
latest from tivo-3: tivozanib for refractory advanced renal cell carcinoma
-
1:15
tivozanib could evaluated in combination regimens for renal cell carcinoma
-
8:11
asco gu 2020: dr. albiges recounts exciting research in rcc
-
2:37
asco gu 2013: enzalutamide monotherapy: phase ii study results - dr bertrand tombal
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
41:41
gregg semenza at gyss 2021 – hypoxia-inducible factors in physiology and medicine
-
1:48:05
ata fellows' track case studies 2011: thyroid cancer
-
1:45
keynote-426: pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma
-
1:11
unboxing organoids (eng)